Non-employment over the working life: Implications for cognitive function and decline in later life.

Public Health Pract (Oxf)

MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.

Published: June 2025

Objectives: Disuse theory predicts that cognitive function is vulnerable to transitions that remove factors that support cognitive skills. We sought to investigate whether non-employment over the working life was associated with cognitive function and decline in later life (≥60 years old), and possible gender differences in the association.

Study Design: Longitudinal study.

Method: We used data from the MRC National Survey of Health and Development (NSHD). Cognitive function was measured by verbal memory and processing speed. Linear regression was used to test associations between non-employment duration and cognitive function at age 60-64, and conditional change models were used to examine associations between non-employment and cognitive decline from age 60-64 to 69. Gender specific models were adjusted for childhood factors and educational attainment, adult occupational features, and adult health and lifestyle indicators. Missing data was accounted for using multiple imputation by chained equations.

Results: In fully adjusted models >15 years non-employment was associated with lower cognitive function at age 60-64 in men (verbal memory: -0.72, 95%CI -1.18, -0.26; processing speed: -0.61, 95%CI -1.00, -0.28), but not women. Fully adjusted models also indicated that long-term and intermediate lengths of non-employment were associated with faster decline in verbal memory (-0.38, 95%CI -0.75, -0.02) and processing speed (-0.28, 95%CI -0.52, -0.03) in men. There was no association between non-employment and cognitive decline among women.

Conclusion: Long-term non-employment in men, but not women, is associated with accelerated cognitive ageing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758421PMC
http://dx.doi.org/10.1016/j.puhip.2024.100563DOI Listing

Publication Analysis

Top Keywords

cognitive function
24
verbal memory
12
processing speed
12
age 60-64
12
cognitive
10
non-employment
8
non-employment working
8
working life
8
function decline
8
decline life
8

Similar Publications

Pharmacological Aspects in the Management of Children and Adolescents with Prader-Willi Syndrome.

Paediatr Drugs

January 2025

Division of Endocrinology, Department of Pediatrics, University of Florida, PO Box 100296, Gainesville, FL, 32610, USA.

Prader-Willi syndrome is a rare neurodevelopmental disorder that impacts the musculoskeletal, endocrine, pulmonary, neurologic, ocular, and gastrointestinal systems. In addition, individuals with Prader-Willi syndrome have issues with cognitive development, characteristic behavioral problems, and perhaps most profoundly, appetite control. Currently, the only US Food and Drug Administration-approved therapy for Prader-Willi syndrome is growth hormone, which has been Food and Drug Administration approved for > 20 years for the treatment of growth failure in Prader-Willi syndrome.

View Article and Find Full Text PDF

Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.

Geroscience

January 2025

Psychology, School of Social Sciences, Nanyang Technological University, 48 Nanyang Avenue S639818, Singapore, Singapore.

In Alzheimer's disease (AD), the accumulation of neuropathological markers such as amyloid-β plaques, neurofibrillary tangles, and cortical neurodegeneration occurs over many years before overt manifestation of cognitive impairment. There is thus a need for neuropsychological markers that are indicative of pathological changes in the early stages of the disease. Intra-individual cognitive variability (IICV), defined as the variation of an individual's performance across cognitive domains, is a promising neuropsychological marker measuring heterogeneous changes in cognition that may reflect these early pathological changes.

View Article and Find Full Text PDF

Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer's disease patients.

Ann Nucl Med

January 2025

Department of Radiological Sciences, School of Health Science, Fukushima Medical University, 10-6 Sakae, Fukushima City, Fukushima, 960-8516, Japan.

Objective: This study aims to accurately classify ATN profiles using highly specific amyloid and tau PET ligands and MRI in patients with cognitive impairment and suspected Alzheimer's disease (AD). It also aims to explore the relationship between quantified amyloid and tau deposition and cognitive function.

Methods: Twenty-seven patients (15 women and 12 men; age range: 64-81 years) were included in this study.

View Article and Find Full Text PDF

EEG involves recording electrical activity generated by the brain through electrodes placed on the scalp. Imagined speech classification has emerged as an essential area of research in brain-computer interfaces (BCIs). Despite significant advances, accurately classifying imagined speech signals remains challenging due to their complex and non-stationary nature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!